Incidence and oncologic outcomes of patients with prostate-specific antigen persistence after radical prostatectomy. Lane BR, Lewicki P, Noyes SL, Labardee C, et al. Cancer 2026;132:e70291.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lane BR, Lewicki P, Noyes SL, Labardee C, et al. Incidence and oncologic outcomes of patients with prostate-specific antigen persistence after radical prostatectomy. Cancer 2026;132:e70291.
PMID: 41645394